Opsens Inc T.OPS

Healthcare Medical Devices

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.

TSX:OPS - Post by User

Opsens Inc > OPSENS ANNOUNCES FOURTH QUARTER RESULTS

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on Nov 22, 2023 11:04am

199 Views

Post# 35748425

OPSENS ANNOUNCES FOURTH QUARTER RESULTS

Total Revenue up 37% - Medical Sales up 42% - Gross Margin 58%

QUEBEC CITY, QC, Nov. 22, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today reported its results for the fourth quarter of fiscal year 2023, ended August 31, 2023.

OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS (newswire.ca)